Benralizumab Improved Total Nasal Symptom Score in Severe Asthma
Among patients with severe asthma, benralizumab treatment improved nasal symptoms, which worsen with increasing baseline blood eosinophil count.
ACAAI 2019
Mepolizumab Significantly Reduces Asthma Exacerbations and Associated Costs
In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs.
Family History of Cancer: A Significant Risk Factor for Childhood Asthma?
Children with a family history of cancer may be more likely to develop childhood asthma.
Ragweed SLIT Tablet Improves Symptoms in Children With Ragweed Allergic Rhinitis
Ragweed sublingual immunotherapy tablet improved symptoms and decreased the need for rescue medication in the largest allergy immunotherapy trial in children with ragweed allergic rhinitis with or without conjunctivitis.
High-Dose Peanut Oral Immunotherapy Safe, Effective for Peanut Allergy
High-dose peanut oral immunotherapy provided similar or greater efficacy than other previously reported forms of peanut oral immunotherapy without additional safety concerns.
FeNO May Assist in Diagnosing Cough Variant Asthma in Chronic Cough
Fractional exhaled nitric oxide values may help in the identification of cough variant asthma in patients with chronic cough.
Budesonide Oral Suspension Improves Dysphagia in Eosinophilic Esophagitis
Budesonide oral suspension was associated with improvements in dysphagia in patients with eosinophilic esophagitis.
Mepolizumab Reduced Eosinophils, Exacerbations in Severe Eosinophilic Asthma
Mepolizumab was associated with reductions in eosinophil levels and asthma exacerbations,
as well as improvements in quality of life in uncontrolled severe eosinophilic asthma.
Pediatric Asthma Plus Atopic Dermatitis Associated With Poor Sleep Outcomes
Asthma plus atopic dermatitis may lead to poorer sleep-specific outcomes in pediatric patients.
Effect of Seasonality on Asthma Exacerbations Before and After Mepolizumab
Mepolizumab reduced the number of exacerbations in patients with severe asthma, but exacerbations per month remained relatively stable throughout the year without a clear seasonal influence.
-
Loading...
-
Loading...
Next post in ACAAI 2019
